Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria

被引:11
|
作者
Isom, Robert [1 ]
Shoor, Stanford [2 ]
Higgins, John [3 ]
Cara-Fuentes, Gabriel [4 ]
Johnson, Richard J. [5 ]
机构
[1] Stanford Univ, Div Nephrol, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA
[2] Stanford Univ, Div Immunol & Rheumatol, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Pathol, Med Ctr, Stanford, CA 94305 USA
[4] Univ Michigan, Div Pediat Nephrol, Ann Arbor, MI 48109 USA
[5] Univ Colorado, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA
来源
KIDNEY INTERNATIONAL REPORTS | 2019年 / 4卷 / 09期
关键词
B7-1;
D O I
10.1016/j.ekir.2019.05.1155
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1349 / 1353
页数:5
相关论文
共 50 条
  • [1] Maximal 'CD80-uria' with minimal change
    Kistler, Andreas D.
    Reiser, Jochen
    KIDNEY INTERNATIONAL, 2010, 78 (03) : 236 - 238
  • [2] Rituximab for Steroid-Dependent Minimal Change Disease in Adults
    Kannan, Lakshmi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 828 - 828
  • [3] Rituximab for Steroid-Dependent Minimal Change Disease in Adults: Is It Time for a Change?
    Kannan, Lakshmi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [4] THE EFFECT OF RITUXIMAB IN ADULTS WITH STEROID-DEPENDENT MINIMAL CHANGE DISEASE
    Lee, M.
    Nicholls, K.
    NEPHROLOGY, 2014, 19 : 94 - 94
  • [5] A case of minimal change disease evolving into steroid-dependent nephrotic syndrome with hematuria
    Jonkers, IJ
    Bruijn, JA
    Vleming, LJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (04) : 773 - 777
  • [6] Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease
    Munyentwali, Helene
    Bouachi, Khedidja
    Audard, Vincent
    Remy, Philippe
    Lang, Philippe
    Mojaat, Rachid
    Deschenes, Georges
    Ronco, Pierre M.
    Plaisier, Emmanuelle M.
    Dahan, Karine Y.
    KIDNEY INTERNATIONAL, 2013, 83 (03) : 511 - 516
  • [7] Frequent-relapsing, steroid-dependent minimal change disease: is rituximab the answer?
    Fervenza, Fernando C.
    Sethi, Sanjeev
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 722 - 727
  • [8] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
    Rodney D. Gilbert
    Eleanor Hulse
    Susan Rigden
    Pediatric Nephrology, 2006, 21 : 1698 - 1700
  • [9] Tacrolimus effective in steroid-dependent minimal change nephrotic syndrome
    不详
    Nature Clinical Practice Nephrology, 2008, 4 (1): : 5 - 6
  • [10] Comparison of treatment options in adults with frequently relapsing or steroid-dependent minimal change disease
    Heybeli, Cihan
    Erickson, Stephen B.
    Fervenza, Fernando C.
    Hogan, Marie C.
    Zand, Ladan
    Leung, Nelson
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (10) : 1821 - 1827